TaiDoc Technology Corporation (TPE:4736)
Taiwan
· Delayed Price · Currency is TWD 138.00
-1.00 (-0.72%)
Jun 6, 2025, 1:30 PM CST
TaiDoc Technology Revenue
TaiDoc Technology had revenue of 976.79M TWD in the quarter ending March 31, 2025, a decrease of -9.42%. This brings the company's revenue in the last twelve months to 4.54B, up 4.45% year-over-year. In the year 2024, TaiDoc Technology had annual revenue of 4.64B, down -3.46%.
Revenue (ttm)
4.54B
Revenue Growth
+4.45%
P/S Ratio
2.90
Revenue / Employee
6.94M
Employees
654
Market Cap
13.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.64B | -166.10M | -3.46% |
| Dec 31, 2023 | 4.81B | -4.82B | -50.07% |
| Dec 31, 2022 | 9.63B | 3.13B | 48.26% |
| Dec 31, 2021 | 6.49B | 589.73M | 9.99% |
| Dec 31, 2020 | 5.90B | 1.77B | 42.65% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Lumosa Therapeutics | 43.59M |
| Center Laboratories | 1.63B |
| Oneness Biotech | 117.33M |